{"id":"NCT01606319","sponsor":"Milton S. Hershey Medical Center","briefTitle":"Acetaminophen Versus Ibuprofen in Children With Asthma","officialTitle":"Acetaminophen vs. Ibuprofen in Children With Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-02","primaryCompletion":"2015-04","completion":"2015-04","firstPosted":"2012-05-25","resultsPosted":"2017-01-16","lastUpdate":"2017-01-16"},"enrollment":300,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma","Wheezing"],"interventions":[{"type":"DRUG","name":"Acetaminophen","otherNames":["tylenol","paracetamol"]},{"type":"DRUG","name":"Ibuprofen","otherNames":["motrin","advil","nonsteroidal anti-inflammatory drug"]}],"arms":[{"label":"acetaminophen","type":"EXPERIMENTAL"},{"label":"ibuprofen","type":"EXPERIMENTAL"}],"summary":"The Acetaminophen Versus Ibuprofen in Children with Asthma study will test the primary hypothesis that in preschool children 12-59 months of age with persistent asthma on standardized asthma therapy, the number of asthma exacerbations requiring systemic corticosteroids will be more frequent in children randomized to receive acetaminophen as compared to those randomized to receive ibuprofen on an as needed basis for fevers and pain.","primaryOutcome":{"measure":"Exacerbation Frequency","timeFrame":"last 46 weeks of 48 week treatment period","effectByArm":[{"arm":"Acetaminophen","deltaMin":0.81,"sd":null},{"arm":"Ibuprofen","deltaMin":0.87,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.67"}]},"eligibility":{"minAge":"12 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":11},"locations":{"siteCount":15,"countries":["United States"]},"refs":{"pmids":["27532828"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":150},"commonTop":["Acute uri","Fever","Allergic rhinitis","Otitis media NOS","Cough"]}}